NewslettersDermal Cell NewsThe Role of GAPDH in the Selective Toxicity of CNP in Melanoma CellsBy Emily Salmini - March 22, 2024019Treatment of melanoma cells and melanocytes with the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) inhibitor heptelidic acid decreased viability to a much higher extent in the cancer cells than in the studied normal cells.[PLOS One]Full Article